Back to search

Article

Usefulness of mirtazapine and SSRIs in late-life depression. Post hoc analysis of the GUNDAM study.

2023-02-22

Abstract excerpt

<h4>Objective: </h4> Mirtazapine and SSRIs are widely prescribed as first-line agents for late-life depression. However, evidence for these drugs is mostly based on non-elderly patients. Therefore, we reanalyzed a randomized controlled trial of mirtazapine versus SSRIs for depression in a sub-population of late-life patients. <h4>Methods: </h4> A randomized controlled trial was conducted with 141 patients, of who...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8cc86298-a574-5aed-9845-0c0a4f73c97c
DOI
10.21203/rs.3.rs-2589875/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Usefulness of mirtazapine and SSRIs in late-life depression. Post hoc analysis of the GUNDAM study.DOI 10.21203/rs.3.rs-2589875/v1
Select a neighboring publication to make it the new centre.